High-Intensity Chemotherapy is Associated with Better Prognosis in Young Patients with High-Risk Diffuse Large B-Cell Lymphoma: A 10-Year Single-Center Retrospective Cohort Study

BACKGROUND: Patients <60 years old with high-risk diffuse large B-cell lymphoma (DLBCL) receiving standard RCHOP(E) treatment display high relapse rates. Here, we compared this standard regimen to a high-intensity regimen in terms of recurrence and long-term survival. MATERIAL/METHODS: Newly diag...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Xiaorong, Xu, Yan, Zhang, Wanggang, Wang, Jin, Cao, Xingmei, Chen, Yinxia, He, Aili, Liu, Jie, Wang, Jianli, Zhao, Wanhong, Yang, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2016
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913830/
https://www.ncbi.nlm.nih.gov/pubmed/27232105
http://dx.doi.org/10.12659/MSM.895383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913830/
https://www.ncbi.nlm.nih.gov/pubmed/27232105
http://dx.doi.org/10.12659/MSM.895383

Ejemplares similares